Clinical Trial Update: Vosoritide for Selected Genetic Causes of Short Stature [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study of Vosoritide for selected genetic causes of short stature, with status currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Stature

Drugs mentioned

• Vosoritide (vosoritide)

Snippet

Sponsor: Andrew Dauber | Conditions: Short Stature | Phase 2 | Status: ACTIVE_NOT_RECRUITING